Teva Pharmaceutical Industries Ltd SEC filings TEVA
Teva Pharmaceutical Industries Ltd has 1,001 filings in SEC EDGAR's recent list, going back to Oct 17, 2017. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 31, 2026 | — |
| DEF 14A | Proxy statement | Mar 31, 2026 | May 28, 2026 |
| DEFA14A | Additional proxy material | Apr 9, 2025 | — |
| DEF 14A | Proxy statement | Apr 9, 2025 | Jun 5, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2024 | — |
| DEF 14A | Proxy statement | Apr 16, 2024 | Jun 6, 2024 |
| DEFA14A | Additional proxy material | May 24, 2023 | — |
| DEFA14A | Additional proxy material | Apr 19, 2023 | — |
| DEF 14A | Proxy statement | Apr 19, 2023 | — |
| DEFA14A | Additional proxy material | Apr 13, 2022 | — |
| DEF 14A | Proxy statement | Apr 13, 2022 | Jun 23, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 15, 2022 | Jun 23, 2022 |
| DEFA14A | Additional proxy material | Apr 21, 2021 | — |
| DEF 14A | Proxy statement | Apr 21, 2021 | Jun 14, 2021 |
| DEFA14A | Additional proxy material | May 26, 2020 | — |
| DEFA14A | Additional proxy material | Apr 22, 2020 | — |
| DEF 14A | Proxy statement | Apr 22, 2020 | Jun 9, 2020 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2020 | Jun 9, 2020 |
| DEFA14A | Additional proxy material | Apr 16, 2019 | — |
| DEF 14A | Proxy statement | Apr 16, 2019 | Jun 11, 2019 |
| DEFA14A | Additional proxy material | Apr 25, 2018 | — |
| DEF 14A | Proxy statement | Apr 25, 2018 | Jun 5, 2018 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TEVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Large accelerated filer
- SEC CIK
- 818686
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED (until Jan 16, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.